Key Highlights
- AQEMIA partners with Sanofi in a pioneering multi-year research collaboration to discover small molecule drug candidates.
- AQEMIA to utilize its unique platform combining deep physics and generative AI, bypassing the need for initial chemical experimental data.
- The collaboration covers the entire drug discovery journey, with AQEMIA eligible for up to $140 million based on research and development milestones.
Source: Business Wire
Notable Quotes
- “This new partnership with Aqemia is part of an ongoing story that began with our French teams three years ago… We have been able to concretely assess the interest in some of our research projects during our previous collaborations.” – Jacques Volckmann, Vice-President R&D France at Sanofi
- “This new collaboration builds on our existing research collaboration with Sanofi for the past two years… We are passionately committed to discovering innovative drugs in close alliance with Sanofi’s experts.” – Maximilien Levesque, CEO and Co-founder at AQEMIA
SoH's Take
This collaboration between AQEMIA and Sanofi represents a significant milestone in the integration of advanced technologies like AI and quantum-inspired physics in drug discovery. AQEMIA’s approach, which forgoes the initial need for chemical experimental data, indicates a paradigm shift in how drug discovery is conducted, potentially speeding up the process significantly. The partnership is not just a testament to the capabilities of AQEMIA’s platform, but also to the growing trend of tech-driven approaches in pharmaceutical research. With the focus on covering the complete drug discovery journey, from initial hits to development candidates, this alliance holds the promise of bringing innovative treatments to market faster, especially for diseases with unmet needs. The substantial financial commitment from Sanofi underlines the potential they see in AQEMIA’s technology and approach. This collaboration could set a new standard in the industry and pave the way for future tech-powered partnerships in healthcare.
